Vanda Pharmaceuticals (VNDA) Tax Rate (QoQ) (2010 - 2026)

Vanda Pharmaceuticals (VNDA) Tax Rate (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.84 Bn 467.05 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Vanda Pharmaceuticals 313.95 Mn 111.64 Mn 48.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27,132.00
Dec 31, 2025 -29,195.00
Sep 30, 2025 -164.00
Jun 30, 2025 100.00
Mar 31, 2025 -388.00
Dec 31, 2024 1,054.00
Sep 30, 2024 -368.00
Jun 30, 2024 699.00
Mar 31, 2024 5,506.00
Dec 31, 2023 -25,812.00
Sep 30, 2023 17,173.00
Jun 30, 2023 83.00
Mar 31, 2023 1,298.00
Dec 31, 2022 -1,166.00
Sep 30, 2022 862.00
Jun 30, 2022 1,712.00
Mar 31, 2022 -325.00
Dec 31, 2021 -1,019.00
Sep 30, 2021 457.00
Jun 30, 2021 636.00